Primus Pharmaceuticals

4 recalls Categories: Prescription Drugs

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Jan 26, 2018 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Jan 26, 2018 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Jan 26, 2018 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Jan 26, 2018 Prescription Drugs Nationwide View Details →